Park Avenue Securities’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
+7,277
New +$184K ﹤0.01% 1727
2022
Q3
Sell
-5,177
Closed -$179K 1178
2022
Q2
$179K Sell
5,177
-12,338
-70% -$458K ﹤0.01% 1075
2022
Q1
$761K Buy
17,515
+2,877
+20% +$125K 0.01% 582
2021
Q4
$726K Buy
14,638
+6,713
+85% +$348K 0.01% 574
2021
Q3
$421K Buy
7,925
+538
+7% +$29.7K 0.01% 712
2021
Q2
$428K Buy
7,387
+1,203
+19% +$68.4K 0.01% 695
2021
Q1
$355K Buy
6,184
+199
+3% +$12.2K 0.01% 714
2020
Q4
$346K Buy
+5,985
New +$322K 0.01% 626

Other funds holding HEAL

Park Avenue Securities's HEAL Position: Q2 2026 in Review

Park Avenue Securities opened a new position in Global X Funds Global X HealthTech ETF (HEAL) in Q2 2026: 7,277 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1727 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in HEAL as recently as Q2 2022.

Park Avenue Securities first reported a position in HEAL in Q4 2020 and has held it in 8 quarters since. The position peaked at $761K in Q1 2022. 9 funds tracked by Wall St. Rank hold HEAL as of Q2 2026.

  • Park Avenue Securities held 7,277 shares of Global X Funds Global X HealthTech ETF worth $201K as of Q2 2026.
  • Global X Funds Global X HealthTech ETF was a new Park Avenue Securities position in Q2 2026.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1727 holding.
  • Park Avenue Securities first reported a position in Global X Funds Global X HealthTech ETF in Q4 2020 and has held it in 8 quarters since.
  • Park Avenue Securities's Global X Funds Global X HealthTech ETF position peaked at $761K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.